US EditionPublished • loading... • Updated
Tuberculosis vaccine shows promise as once-fatal disease evades treatment
The vaccine targets drug-tolerant TB persisters and, with antibiotics, cut bacterial load, reduced lung inflammation and prevented relapse in mice, researchers said.
Summary by The Union Democrat
2 Articles
2 Articles
The Union DemocratReposted by 
The spokesman-Review
The spokesman-ReviewTuberculosis vaccine shows promise as once-fatal disease evades treatment
Tuberculosis infected more than 8 million people in 2024 — surpassing COVID-19 and marking a record high since 1995 — as a new Johns Hopkins-developed vaccine emerges amid rising antibiotic resistance.
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
